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Introduction
Human cytomegalovirus (HCMV) infection is the most common congenital viral infection in humans, 
with approximately 20,000 infants with congenital HCMV (cCMV) infections born every year in the Unit-
ed States (1, 2). Of  these, about 3,000 infants with cCMV infection will develop long-term neurological 
damage, including sensorineural hearing loss (SNHL) in approximately 12% of  infected infants (3–6). The 
degree of  hearing loss (HL) in infected infants is highly variable, ranging from moderate to profound, 
and can be unilateral or bilateral (7, 8). In addition, HCMV-infected infants can experience late-onset HL 
months to years after birth (1, 7). Although antiviral drugs are used to treat infants with severe cCMV 
infection, their toxicity has restricted their use in pregnant women due to potentially teratogenic effects in 
the fetus (9). Studies of  the inner ears (cochlea) of  terminated human fetuses infected with HCMV have 
described virus-infected cells in cochlear structures, including the stria vascularis, spiral ganglion neurons 
(SGN), supporting cells (SCs), and Reissner’s membrane (10, 11). Abundant mononuclear cell infiltrates 
were also noted (10, 11). Other congenital virus infections such as rubella are believed to cause SNHL 
through a mechanism of  direct viral damage to the cochlea, resulting in cell death in the organ of  Corti and 
damage to the stria vascularis (12, 13).
To study the pathogenesis of  SNHL in cCMV infection, we have developed a mouse model in which 
newborn mice are infected i.p. with nonlethal doses of  murine CMV (MCMV), a virus with high genetic relat-
edness, similar replication program, and commonalities in biologic behavior with HCMV (14). Following i.p. 
injection of  MCMV, the virus spreads hematogenously to the CNS (including the cochlea). This model relies 
on the observation that, developmentally, the auditory system of the newborn mouse is similar to that of  an 
early second trimester human fetus. The auditory system in mice develops postnatally, and although the onset 
of  hearing is around P12–P14, the auditory system fully matures around P20 (15–18). Thus, this model has 
allowed investigation of  the impact of  virus infection during the development of  the auditory system.
Although human cytomegalovirus (HCMV) is a known cause of sensorineural hearing loss in 
infants with congenital HCMV (cCMV) infections, mechanisms that contribute to sensorineural 
hearing loss (SNHL) in infants with cCMV infection are not well defined. Using a murine model of 
CMV infection during auditory development, we have shown that peripheral infection of newborn 
mice with murine CMV (MCMV) results in focal infection of the cochlea and virus-induced cochlear 
inflammation. Approximately 50%–60% of infected mice exhibited increased auditory brainstem 
response (ABR) thresholds across a range of sound frequencies. Histological analyses of the 
cochlea in MCMV-infected mice with elevated ABR thresholds revealed preservation of hair cell (HC) 
number and morphology in the organ of Corti. In contrast, the number of spiral ganglion neurons 
(SGN), synapses, and neurites connecting the cochlear HC and SGN nerve terminals were decreased. 
Decreasing cochlear inflammation by corticosteroid treatment of MCMV-infected mice resulted 
in preservation of SGN and improved auditory function. These findings show that virus-induced 
cochlear inflammation during early auditory development, rather than direct virus-mediated 
damage, could contribute to histopathology in the cochlea and altered auditory function without 
significant loss of HCs in the sensory epithelium.
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We previously demonstrated that MCMV infection in newborn mice resulted in a moderate to 
severe increase in auditory brainstem response (ABR) thresholds in approximately 40%–50% of  infect-
ed mice (19). Increasing the inoculum size increased the incidence of  animals exhibiting elevated 
thresholds and resulted in higher incidence of  mice with more severe ABR abnormalities (19). In addi-
tion, about 30% of  infected mice exhibited progressive increases in ABR thresholds within the first 3 
months of  life (19). Thus, phenotypes of  HL in MCMV-infected mice recapitulated several of  the most 
salient clinical features of  HL that follow cCMV infection in infants. Our previous findings in this mod-
el indicated that MCMV infection during auditory development resulted in HL in infected mice that 
could not be correlated with the amount of  virus in the cochlea but, instead, was associated with the 
expression of  virus-induced proinflammatory cytokines and chemokines in the cochlea (19). However, 
in this earlier study, we did not comprehensively describe the impact of  MCMV infection on the mor-
phology of  cochlear structures that could contribute to elevated ABR thresholds. In the current study, 
we have cataloged the histopathological changes within the cochlea of  MCMV-infected animals and 
identified multiple lesions that could contribute to HL in MCMV-infected mice. Surprisingly, we found 
no evidence of  hair cell (HC) loss in mice with elevated ABR thresholds, arguing that the mechanism of  
HC dysfunction in this model remains to be defined. In addition, we directly tested the hypothesis that 
virus-induced inflammation, and not lytic virus replication, resulted in the observed histopathological 
and functional abnormalities in the mature cochlea of  mice infected in the newborn period by treat-
ing infected mice with corticosteroids. Our results were consistent with virus-induced inflammation 
as a mechanism of  SNHL and histopathological findings in the cochlea of  mice infected with MCMV 
during auditory development. These findings raised the possibility that similar mechanisms could con-
tribute to SNHL associated with cCMV infections in infants.
Results
MCMV replicates in the cochlea of  newborn mice and induces robust inflammatory responses. To define the kinet-
ics of  cochlear infection with MCMV, newborn mice (P0) were injected i.p. with 500 PFU MCMV, and 
MCMV DNA was quantified in cochlea from P4–P44. In contrast to our previous studies, we utilized a 
molecular clone of  the Smith strain of  MCMV (MCMV-repaired) that represented a homogenous popula-
tion of  virus (14, 19). MCMV DNA was initially detected on P4 and reached peak levels by P12, with viral 
DNA declining throughout the postnatal period (Figure 1A). MCMV infection was focal in the cochlea, 
with small numbers of  MCMV-infected cells present in foci that were, in turn, widely scattered throughout 
the cochlea (1–2 foci/section) (Figure 1B) (14, 20). MCMV-infected cells were detected in SGNs in the 
modiolus and the stria vascularis (Figure 1B) (19). However, analysis of  multiple sections from a large 
number of  cochleae failed to reveal any evidence of  virus infection in resident cells of  the organ of  Corti 
(Figure 1B). Together, these data indicate that, following peripheral infection in newborn mice, the virus 
spread hematogenously to the cochlea and established foci of  infection in several regions of  the cochlea, 
but importantly, it spared cells of  the sensory epithelium in the cochlea.
To define the kinetics of  virus-induced inflammation in the cochlea, we quantified expression of  an 
interferon-stimulated gene (ISG), IFIT1, and a proinflammatory cytokine, TNF-α, in the cochlea of  infect-
ed mice between P4–P44. Consistent with the increase in viral DNA during the first 12 days after infection, 
the expression of  IFIT1 increased significantly and then decreased as virus was cleared from the cochlea 
(Figure 1C). In contrast, expression of  TNF-α in cochlea peaked slightly later and decreased more slow-
ly than the expression of  IFIT1 (Figure 1D). In addition, mononuclear cells expressing Iba-1, a mark-
er for activated cells of  the myeloid lineage, were increased in P8 cochlea in infected mice as compared 
with controls (Figure 1B). Of  note, in some sections, Iba-1+ mononuclear cells accumulated near foci of  
MCMV-infected cells (Figure 1B). Together, these results indicated that, following MCMV dissemination 
and establishment of  a focal infection in the inner ear, a robust inflammatory response characterized by 
the expression of  ISGs, proinflammatory cytokines, and activated myeloid cells could be detected in the 
cochlea early after infection.
MCMV infection in newborn mice is associated with altered auditory function in young adult mice in the absence of  
HC loss. To confirm that cochlear infection in newborn mice resulted in altered auditory function, we utilized 
ABR testing to quantify evoked potentials in the mouse cochlea and brain in response to auditory stimuli in 
noninfected control mice and in mice infected as newborns with either 200 or 500 PFU of MCMV. Hearing 
was measured at P32, a time point that virtually assured that the auditory system would be fully mature in all 
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mice (15–17). Auditory stimuli were provided to mice in the form of broadband click stimuli (Figure 2A) and 
frequency-dependent pure tones ranging from 4–48 kHz (Figure 2B) to measure hearing thresholds as defined by 
the lowest intensity stimulus (dB) at which ABR waveforms could be detected. The median of ABR thresholds 
in the group of MCMV-infected animals, measured by both broadband click and pure tone, were significantly 
elevated compared with a noninfected, control group of animals (Figure 2, A and B). Ears from MCMV-infected 
animals showed significant increases in the ABR threshold at all frequencies when compared with noninfected 
controls, suggesting that impairment in auditory function was generalized and not limited to a specific region in 
the cochlea (Figure 2B). We also assessed the function of outer HCs (OHC) using distortion product otoacoustic 
emission (DPOAE) testing (Figure 2C). Mice with elevated ABR thresholds measured by broadband click exhib-
ited increased DPOAE thresholds at all frequencies, thus providing evidence of OHC dysfunction in infected 
mice (Figure 2C). Lastly, we quantified the amplitude and latency of wave I of the ABR as measures of the 
conduction of the output from the inner HCs (IHC) in the cochlea (Figure 2D). MCMV-infected animals with 
ABR click thresholds between 60 and 90 dB, indicative of severe HL, displayed impairment in the amplitude of  
ABR wave I growth measured at 8 and 32 kHz frequencies, while infected animals with normal ABR thresholds 
displayed comparable amplitude of ABR wave I growth compared with the noninfected, control animals (Figure 
3, A and B). Furthermore, the latency of wave I was delayed in infected mice with significant elevations of ABR 
thresholds, whereas there were no significant delays in latency in infected animals with normal ABR thresholds 
Figure 1. I.p. inoculation of newborn mice with MCMV results in cochlear infection and inflammation. (A) MCMV DNA was extracted from the cochlea 
and quantified as described in Methods, with each data point representing genome copy number in single cochlea. (B) Representative images of cochleae 
from noninfected, control (top) and MCMV-infected (bottom) mice displaying inflammatory response. Midmodiolar cochlear sections of P8 MCMV-infected 
mice were immunostained for MCMV IE-1 protein (green) and Iba-1 (red), a marker for activated myeloid cells, and nuclear stain (blue) (10× magnification). 
A higher-magnification of area of interest (boxed area) in cochlea from MCMV-infected mouse is shown on the right (40× magnification). A total of n = 3 
mice/n = 6 cochleae were stained. Scale bars: 100 μm. (C) Expression of interferon-stimulating gene (ISG), IFIT1, and (D) proinflammatory cytokine TNF-α 
were measured by reverse transcription PCR at various time points from RNA extracted from cochlea as described in Methods. HPRT was used as internal 
control, and fold change was normalized to the noninfected, control cochlea. For each time point, n = 4–6 mice were assayed.
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(Figure 3, C and D). Collectively, these results suggested that MCMV infection in some but not all newborn mice 
led to moderate to severe loss of normal auditory functions, as measured by ABR and DPOAE testing, and alter-
ations in the amplitude and latency of ABR wave I that, when viewed together, represent the summated response 
from SGNs and cranial nerve VIII.
The number of  HCs and SC subtypes, specifically Deiters’ cells, in MCMV-infected and control mice on 
P32 were compared to determine if  increased thresholds detected in ABR and DPOAE testing in MCMV-in-
fected mice was accompanied by damage or loss of  cells in the sensory epithelium. For these experiments, 
cochleae from mice with ABR thresholds above 60 dB were compared with cochleae from noninfected, con-
trol animals. Immunological identification of  HCs (MyosinVIIa) and Deiters’ cells (Sox2), nonsensory cells 
located adjacent to OHC, revealed comparable numbers of  IHC, OHC, and Deiters’ cells in the cochlea of  
noninfected (ABR threshold of  30 dB) and MCMV-infected mice (ABR threshold of  75 dB) (Figure 4). This 
indicated that the elevation of  ABR and DPOAE thresholds in MCMV-infected mice were not associated 
with loss of  HC or Deiters’ cells or with recognizable morphological changes at the level of  conventional 
confocal microscopy in these cell types when compared with similar preparations from noninfected, control 
mice with normal ABR thresholds. Thus, in this model of  virus-induced HL, elevation of  ABR thresholds 
secondary to HC dysfunction is present in the absence of  overt loss or damage of  the sensory epithelium.
MCMV-infected mice display reduced numbers of  inner HC synapses and neurite density. To further define 
the impact of  MCMV infection and virus-induced inflammation during early cochlear development, we 
quantified the number of  synapses between HCs and the SGN nerve terminals. The organ of  Corti from 
Figure 2. MCMV infection of newborn mice results in moderate to severe hearing loss. (A–C) ABR thresholds determined 
at P32 in noninfected control mice and mice infected as newborns with 200 or 500 PFU of MCMV. (A) Broadband clicks 
were presented to the animals in the following groups: noninfected, n = 18 mice/36 ears; 200 PFU MCMV n = 27 mice/54 
ears; 500 PFU MCMV n = 24 mice/48 ears. P values calculated with 1-way ANOVA (Kruskal-Wallis test) with Dunn’s 
comparisons test. (B) Frequency-dependent tone-pips were used to determine the ABR thresholds in control and infected 
mice. Data shown as mean ± SD; noninfected control mice (blue solid line), n = 12 mice/24 ears; 200 PFU (red dashed line) 
MCMV, n = 27 mice/54 ears; and 500 PFU (red solid line) MCMV, n = 12 mice/24 ears. (C) For DPOAE testing, noninfected 
control mice (blue solid line), n = 8 mice/16 ears, and infected mice with elevated ABR click thresholds above 60 dB (red 
solid line), n = 7/14 ears were used. P values for frequency tone-pip and DPOAE were determined by 2-tailed unpaired t 
test (Mann-Whitney U test). (D) Sample ABR tracings from noninfected, control mouse (black) and MCMV-infected mouse 
(red) with ABR threshold of 25 dB and 75 dB, respectively, measured with broadband clicks. Note designation of wave I in 
control tracing with amplitude expressed in µV and latency in msec. *P < 0.05; **P < 0.01; ****P < 0.0001.
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P32 mice was dissected and stained for Carboxy-terminal Binding Protein 2 (CtBP2), which labeled 
presynaptic ribbons found in IHC, and for GluR2, an AMPA receptor subunit that labeled postsynaptic 
glutamate receptors on afferent nerve terminals (21, 22). Low-magnification images were taken to mea-
sure cochlear length to convert cochlear regions to relevant cochlear frequencies. Subsequently, high-
er-magnification images were collected using confocal z-stacks to quantify the number of  synapses per 
IHC (23). Regions of  the cochlea corresponding to frequencies of  16 kHz (apex) and 32 kHz (mid) are 
shown, and synapses from additional images of  regions corresponding to 40 kHz (base) were quantified 
in cochlea from MCMV-infected mice with elevated ABR thresholds and noninfected control mice 
(Figure 5A). The number of  CtBP2 puncta, GluR2-labeled terminals, and paired CtBP2/GluR2 ribbons 
and terminals were used to define the number of  intact synapses (Table 1). The number of  synapses was 
reduced in IHCs located in the apical and mid regions, but not in the basal region, in the cochlea from 
MCMV-infected mice with increased ABR thresholds as compared with cochleae from control animals 
with normal ABR thresholds (Figure 5A and Table 1).
To determine the impact of  virus infection and inflammation on the integrity of  innervation of  HC in 
the cochlea, we imaged nerve fibers in the sensory epithelium of  MCMV-infected and noninfected mice 
by immunostaining P32 cochlear wholemounts for neurofilament heavy chain (NF-H). As the density of  
innervation is different from the apex to basal regions of  the cochlea, confocal z-stack images were taken 
from frequency-matched regions along the organ of  Corti (21). In cochleae from MCMV-infected mice 
with elevated ABR thresholds, nerve fibers (Type II SGN) that directly innervate the OHCs were disorga-
nized, with abnormal positioning of  the nerve fibers when compared with those from noninfected, con-
trol mice (Figure 5B and Supplemental Figure 4, A and B; supplemental material available online with 
Figure 3. Impaired wave I growth and latency in MCMV-infected mice. Wave I amplitude and latency of noninfected, control mice (black lines) compared 
with MCMV-infected mice (red lines) grouped according to ABR broadband click thresholds; 2 groups of animals that measured ABR thresholds between  
(A and C) 30–40 dB and (B and D) 60–90 dB are shown. Wave I amplitudes and latencies were measured from ABR tracings at indicated frequencies (8, 32, 
40 kHz) and plotted against sound levels (dB SPL). P values calculated using standard 2-tailed t test. All error bars represent ±SD from n = 15 noninfected 
ears and n = 23 MCMV-infected ears.**P < 0.01; ***P < 0.001; ****P < 0.0001.
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this article; https://doi.org/10.1172/jci.insight.128878DS1). In addition, the comparison of  fluorescence 
intensities of  NF-H under identical image acquisition settings suggested reduced density of  Type I neurites 
around the basolateral region of  the IHCs in cochleae of  infected mice. The reduced density was more 
evident in Type II neurites innervating the OHCs in infected mice with elevated ABR thresholds compared 
with the noninfected control mice (Figure 5B and Supplemental Figure 4). When the total number of  neu-
rites innervating the OHCs in each region was quantified per length of  epithelium, we noted a decrease in 
the overall number of  neurite projections in infected mice with elevated ABR thresholds as compared with 
control mice with normal ABR thresholds (Figure 5C).
Loss of  SGNs in the cochlea of  mice infected with MCMV. To further define the association between the 
loss of  SGN and HL in MCMV-infected mice that we previously described, we quantified the density 
of  SGNs in P32 mice infected as newborns but with different ABR thresholds (19). SGN soma quan-
tification from all 3 regions of  the cochlea (apex, mid, and base) revealed that the SGN density was 
decreased with increasing ABR thresholds (Figure 6). Although a loss of  SGNs in MCMV-infected 
mice was present at all frequency regions of  the cochlea in mice with ABR thresholds > 60 dB, the 
loss of  SGNs was more striking in the apex and mid-portions of  the cochlea than in the basal region 
in mice with moderate increases in ABR thresholds, a distribution that was similar to the loss of  IHC 
synapses as described above (Figure 5A, Figure 6C, and Table 1). Furthermore, there was a gradient of  
SGN loss from the apex to the base in infected mice with ABR click thresholds between 45–55 dB (Fig-
ure 6C). These results suggested that increasing impairment of  auditory function in MCMV-infected 
mice, as measured by ABR, was also associated with increased loss of  SGNs, raising the possibility of  
a common mechanism of  damage following MCMV infection (19).
Figure 4. The number of sensory HCs and SCs in the organ of Corti are not altered by MCMV infection. (A) Cochleae were microdissected into 3 regions 
(apex, mid, and base) and immunostained for MyosinVIIa, a marker for inner and outer hair cells, and Sox2, a marker for supporting cells. Z-stack images 
were acquired at 40× magnification and representative images from the apical region are shown. Scale bars: 40 μm. (B–D) Quantification of the total 
number of IHC (B), OHC (C), and SCs (Deiters’ cells) (D) in the span of 100 μm of the 3 regions displayed no significant differences in the noninfected and 
MCMV-infected cochlea. Data are shown as mean ±SD, n = 4 mice/n = 8 cochlea per experimental group. P values calculated using 2-tailed t test. These 
results were derived from 2 independent experiments.
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Decreasing cochlear inflammation in MCMV-infected mice can limit early damage to the developing auditory system 
and impairment of  auditory function. Previously, we have argued that MCMV-induced inflammation in the 
developing CNS and cochlea contributed significantly to altered neurodevelopment and HL in mice infected 
as newborns (19, 20, 24). The levels of  virus replication in P32 mice infected as newborns compared with 
their respective ABR thresholds failed to reveal a correlation between viral load and the degree of  auditory 
dysfunction, as measured by ABR (Figure 7, A and C). In contrast, when ABR thresholds were compared 
with the level of  IFIT1 expression as a marker of  cochlear inflammation, there was a significant correla-
tion between the level of  inflammation and ABR thresholds (Figure 7, B and D). Further evidence of  the 
nonlinear relationship between cochlear inflammation and elevation of  ABR thresholds was provided by 
Figure 5. MCMV infection results in reduced HC-SGN synapse density in the apex-middle region of the cochlea and disrupts morphology of SGN nerve 
fibers innervating sensory HCs. (A) Magnifications of 130× and 200× high-resolution confocal images were acquired by a z-stack series spanning the 
synaptic regions of the IHCs, and a series of z-stack images were merged, showing juxtaposed presynaptic ribbons (CtBP2; red) and postsynaptic receptors 
(GluR2; green) for P32 mice cochlear wholemounts. Hoechst (blue) was used to stain the nucleus. Representative images of apex (16 kHz) and mid (32 kHz) 
are shown in cochlea from a noninfected mouse and MCMV-infected (500 PFU) mouse with elevated ABR thresholds. White U-shaped outlines indicate 
a selected IHC and associated synapses. Note that anti-CtBP2 antibody also stains IHC nuclei. Scale bar: 20 μm (B) Representative images of P32 mice 
cochlea immunostained for NF-H (green; neurofilament heavy chain) and Hoechst (red; nuclear stain) in the mid-apical (16 kHz) region of the cochlea. Top 
2 panels are xy projections, and bottom 4 panels are xz projections displaying the cross-section of the field of white dashed line. Scale bar: 40 μm (C) The 
number of Type II neurite projections, which innervate the OHCs, in the span of 100 μm of the 3 regions displayed reduced numbers in MCMV-infected 
cochlea compared with the noninfected control. Data are shown as mean ±SD, n = 4–5 mice/n = 6–10 cochlea per experimental group. P values were calcu-
lated using a standard 2-tailed t test. These results were derived from 2 independent experiments. *P < 0.05; **P < 0.01; ****P < 0.0001.
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the analysis of  both ears from an individual MCMV-infected mouse that exhibited > 10 dB differences in 
ABR threshold between ears. In 5 mice meeting this criterion, we noted that, in 4 animals, the ear with the 
higher ABR threshold also had a higher expression of  IFIT1 without a significant difference in the viral load 
in each ear (Figure 7E). Thus, when ABR thresholds from the right and left ears were used as a measure of  
damage to auditory pathways in individual animals, inflammation but not viral load remained associated 
with increased ABR threshold. Lastly, there was no correlation between cochlear virus load and the level 
of  IFIT1 expression, suggesting that, although virus must be present in the cochlea to induce inflammation, 
parameters that govern the magnitude and perhaps the distribution of  the host inflammatory responses in 
the virus-infected cochlea are not linearly related to total cochlear viral load (Supplemental Figure 1).
To determine if  SGN loss occurred early after infection and during development of  the auditory 
system, we measured the density of  SGN soma from P8 noninfected, control and MCMV-infected mice 
(25, 26). Notably, SGN density in P8 cochleae was lower in all frequency regions in MCMV-infected 
mice compared with the noninfected, control mice (Supplemental Figure 2, A and B). In addition, 
there was no difference in the number of  SGNs expressing cleaved Caspase 3 (Casp3a) in noninfected, 
control, and infected mice, suggesting that apoptosis was not a mechanism for loss of  SGNs following 
MCMV infection (Supplemental Figure 2C).
To define the contribution of  virus-induced inflammation to cochlear histopathology that was 
observed early after infection, we treated mice infected as newborns with methylprednisolone sodium 
succinate (pred), a corticosteroid with potent antiinflammatory activity, or vehicle alone from P3–P7 and 
harvested cochleae on P8 (Supplemental Figure 3A). Treatment with pred did not alter the quantity of  
virus in the cochlea but decreased the expression of  the ISG, IFIT1, in the cochlea (Figure 8, A and B). 
We next analyzed the effect of  pred treatment during early postnatal development on the MCMV-induced 
SGN loss, as this histopathologic measure of  virus-induced damage reflected the impact of  MCMV infec-
tion on the cochlea both early in development and at later time points when auditory pathways are mature 
(19). Treatment with pred significantly reduced SGN loss in P8 MCMV-infected animals, as compared 
with infected animals treated with vehicle alone (Figure 8C). Notably, the SGN densities in the apex 
and mid-portion of  the cochlea in pred-treated animals were not significantly different than the SGN 
density in noninfected, control animals treated with vehicle alone (Figure 8C). These results showed that 
virus-induced inflammation contributed to histopathological findings in the developing cochleae that were 
observed shortly after MCMV infection in newborn mice.
The results described above raise the possibility that dampening virus-induced inflammatory responses 
during early cochlear development could improve auditory function in infected mice. To explore these possibil-
ities, noninfected, control mice and MCMV-infected mice were treated with vehicle or pred utilizing a similar 
protocol as described above, but treatment was extended through P20 with a short taper of dosage beginning 
on P17 (Supplemental Figure 3B), thus providing an antiinflammatory effect of pred during resolution of  
cochlear inflammation (Figure 1C). Importantly, the ABR thresholds of noninfected, control mice following 
prolonged treatment with pred did not differ from the noninfected, control group treated with vehicle only, indi-
cating that pred treatment did not alter auditory function in noninfected, control mice (Figure 9A). However, 
prolonged treatment of infected mice with pred resulted in a significantly increased mortality rate, as a group of  
pred-treated MCMV-infected mice had a small but significant improvement in the number of ears with normal 
ABR thresholds (<40 dB) compared with infected mice treated only with vehicle (Figure 9A).
Table 1. Quantification of CtBP2, GluR2, and paired CtBP2/GluR2 puncta associated with IHCs in the apex, middle, and base regions in 
the cochleae of noninfected, control, and MCMV-infected mice
CtBP2 GluR2 CtBP2/GluR2
Control MCMV P value Control MCMV P value Control MCMV P value
Apex 17.236 ± 0.6 15.428 ± 0.99 0.0026 17.035 ± 0.86 15.821 ± 0.79 0.0013 16.507 ± 0.97 14.304 ± 0.94 0.0016
Mid 17.700 ± 0.26 15.638 ± 1.01 0.0039 17.500 ± 0.44 15.439 ± 1.14 0.0013 16.633 ± 0.78 14.750 ± 0.95 0.0172
Base 14.208 ± 2.35 13.500 ± 1.14 0.1206 14.067 ± 2.29 13.146 ± 1.02 0.1089 13.658 ± 2.31 12.917 ± 1.01 0.495
Data are shown as mean ± SD; n = 4 mice/n = 8 cochlea per experimental group. P values were calculated using 2-tailed t test. This experiment was 
repeated 3 times independently. The quantification of CtBP2, GluR2, and costained CtBP2/GluR2 associated with IHCs were reduced in apex and middle 
regions but not in basal region of the cochlea in MCMV-infected mice.
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To further define the impact of  pred treatment on observed abnormal auditory functions in MCMV-in-
fected mice, we determined the growth of  the ABR wave I amplitude and latency at 8 and 32 kHz in con-
trol mice and MCMV-infected mice treated with either vehicle or pred. Treatment of  infected mice with 
pred normalized wave I amplitude growth and latency when compared with infected mice treated with 
vehicle alone (Figure 9, B–E). Moreover, there was no difference in wave I amplitude growth and latency 
between pred-treated infected mice with elevated ABR thresholds and vehicle-treated but noninfected, 
control mice (Figure 9, B–E). Together, these data show that a reduction in virus-induced inflammation 
during cochlear development led to measurable improvements in auditory function in young adult mice 
and provide support for the hypothesis that inflammation and not lytic virus infection contributed to the 
altered function of  auditory pathways in newborn mice infected with MCMV.
To determine if  the impact of  pred treatment on auditory function was also reflected in the preser-
vation of  SGN, thus providing a histopathological correlate of  the impact of  pred treatment on these 
mice, SGN soma density was quantified in MCMV-infected mice or control mice treated with pred or 
vehicle on P34 following ABR testing. Similar to our previous findings, the quantification of  SGNs 
demonstrated a decreased density of  SGNs in vehicle-treated MCMV-infected mice as compared with 
vehicle-treated, noninfected mice in all 3 regions of  the cochlea (Figure 10). Importantly, pred treat-
ment of  infected mice prevented SGN loss when compared with infected mice treated with vehicle 
only, thus providing further evidence that MCMV-induced inflammation was at least one mechanism 
of  damage of  the cochlea in MCMV-infected mice (Figure 10).
Figure 6. ABR elevation in MCMV-infected mice is associated with the level of SGN loss. P32 sections from noninfected, control and MCMV- 
infected (500 PFU) mice were stained for Tuj-1 to detect SGNs. (A) A 10× image of cochlea stained for Tuj-1 displaying the 3 regions (apex, mid, and 
base) of the Rosenthal’s canal. SV, Scala Vestibuli; SM, Scala Media; ST, Scala Tympani; SGN, Spiral Ganglion Neuron. (B) Representative images 
(40×) of SGNs of P32 cochlea from infected mice with elevated ABR threshold (60–90 dB) demonstrate reduced number of SGN soma compared 
with the noninfected control cochlea with normal ABR thresholds (30–40 dB). (C) Cochleae from P32 mice were grouped according to their ABR 
click thresholds. SGNs were quantified and normalized to the areas of Rosenthal’s canal to provide SGN density (cells/10,000 μm2) in the 3 regions 
of the cochlea. SGN quantification data of cochlear sections are shown as mean ± SD, n = 3 mice/6 cochlea per experimental group. P values were 
calculated using 1-way ANOVA with Tukey’s multiple comparison’s test. Data are representative of 2 independent experiments. Scale bars: 100 μm. 
*P < 0.05; **P < 0.01; ***P < 0.001.
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Discussion
SNHL remains the most common long-term sequelae of  cCMV infection, yet mechanisms leading to 
SNHL in infected infants are undefined (7, 27). Much of  the histopathology described in studies of  tem-
poral bones from fetuses infected in utero with HCMV has been recapitulated in this murine model of  
cCMV-associated HL, and infected mice exhibit a clinical spectrum of  SNHL similar to that described 
in cCMV-infected infants (1, 7, 19). Furthermore, in this model, significant variability is observed in the 
level of  ABR threshold elevation in individual animals, a well-described observation in clinical studies of  
SNHL in infants with cCMV. Notably, the variation in the severity of  HL in this model can be observed 
when littermate mice are inoculated with equivalent amounts of  a molecularly cloned virus, suggesting 
that multiple mechanisms could contribute to CMV-induced SNHL. Although this mouse model does 
not recapitulate intrauterine transmission of  virus, when infected, newborn mice (P0) are neurodevelop-
mentally and immunologically similar to early second trimester human fetus, and auditory maturation in 
mice is not complete until about the third postnatal week, with the onset of  hearing between P12–P14. 
Thus, in this model system, virus infection in the cochlea takes place during early cochlear development, 
including a critical period for connectivity of  neural pathways.
We cataloged inner ear histopathology in young adult mice (P32–P34) infected in the newborn period 
with evidence of  moderate to severe elevations in ABR thresholds. Although we could readily demonstrate 
elevated ABR and DPOAE thresholds in a subset of  the infected mice, we found no evidence of  viral infection 
Figure 7. Cochlear inflammation, and not viral load, in MCMV-infected mice correlates with ABR threshold. (A) MCMV genome copy number/mg 
cochlear tissue is plotted vs. ABR threshold of individual mice. (B) IFIT1 expression plotted against the ABR threshold in individual mice. The differ-
ences between groups are determined with 1-way ANOVA with Tukey’s multiple comparison’s test. (C and D) The correlation between the cochlear 
viral load (C) or IFIT1 expression (D) and ABR thresholds are shown. Linear regression analysis was performed, and P value, as a test for linear trend, 
is shown. Note that only the correlation between IFIT1 expression and ABR thresholds (D) reached statistical significance (P = 0.0145). (E) Expres-
sion of IFIT1 and viral load from individual infected mice that displayed more than 10 dB difference in ABR thresholds between right and left ear 
were determined. ABR thresholds from individual mice were plotted against IFIT1 fold change, and viral load (genome copy) is shown in parentheses 
adjacent to each data point. Data points (red open circles) representing cochleae from individual mice are connected by a solid line indicating positive 
correlation, while data points (red close circles) connected by dashed line indicate negative correlation between ABR threshold and IFIT1 fold change. 
Five mice with unilateral HL were analyzed from total experimental group of 9 MCMV-infected mice with elevated ABR thresholds. ***P < 0.001.
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in the sensory epithelium, nor evidence of  significant damage of  the sensory epithelium, including a loss of  
HCs in mice with elevated thresholds. These findings were in striking contrast to results from murine models 
utilizing intracerebral (i.c.) inoculation of  MCMV in which i.c. infection of  newborn mice with MCMV 
consistently produces a significant loss of  the sensory epithelium and corresponding elevations of  ABR and 
DPOAE thresholds in almost all infected animals (28–31). The route of  viral spread to the inner ear following 
i.c. injection vs. that following hematogenous spread is distinctly different and could account for differences in 
experimental findings in these different models (28–31). It was of  interest that we observed a gradient of  SGN 
loss from apical to basal turn with more neuronal loss in the apical region compared with the basal region. 
In contrast, young rodents inoculated with bacteria into the cisterna magna to produce meningitis exhibited 
the most significant loss of  SGN in the basal turn of  the cochlea, with loss of  SGN in the middle and apical 
turns being observed only in animals with significant HC loss and ABR thresholds > 90 dB (32). Similarly, we 
observed a gradient of  loss of  IHC synapses in mice with elevated ABR thresholds, with more loss of  synaps-
es in the apical region of  the cochlea, whereas the basal region was more affected in infant rats with bacterial 
meningitis (32). These different animal models of  inner ear infection leading to HL suggest different routes of  
microbial spread, resulting in differential susceptibilities of  the apical and basal regions of  the cochlear duct. 
In these models of  HL induced by intracisternal inoculation of  bacteria, it has been argued that bacteria as 
well as the resultant inflammatory response spread from the cerebrospinal fluid (CSF) to the cochlea via the 
cochlear aqueduct (32). Our findings suggest that hematogenous spread of  virus in mice infected peripherally 
with MCMV results in a different route of  virus entry into the cochlea.
Figure 8. Prednisolone treatment decreases cochlear inflammation and loss of SGNs in P8 mice infected with MCMV. 
(A) MCMV DNA is quantified and represented as log genome copy/mg cochlear tissue. Note that pred treatment did not 
affect MCMV replication in the cochlea. (B) The impact on the expression of IFIT1 in cochlea of pred-treated, infected 
animals is shown. Note significant differences between the means of the cochlea from MCMV-infected mice vs. those 
from pred-treated MCMV-infected mice. (C) SGNs were quantified in 3 regions of cochlea. SGN density were plotted for 
noninfected, control mice given only vehicle (Cv), noninfected, control mice given pred (Cp), MCMV-infected mice treat-
ed with only vehicle (Mv), and MCMV-infected mice treated with pred (Mp). Medians were analyzed by 1-way ANOVA 
(Kruskal-Wallis test) with Dunn’s post test comparisons test. *P < 0.05; **P < 0.01.
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We detected only widely scattered small foci of  MCMV-infected cells in the modiolus and the stria vas-
cularis in P8 mice infected as newborns — findings inconsistent with a mechanism of cochlear damage sec-
ondary to direct virus-mediated cytopathology (Figure 1B) (19). Furthermore, we documented the expression 
of  the ISGs and proinflammatory cytokines in the cochlea early after infection, as well as dense but evenly 
distributed Iba-1+ myeloid cells throughout the cochlea (Figure 1B). Thus, it is possible that unregulated host 
inflammatory responses to viral infection in the cochlea leads to pathology and HL, as has been suggested in 
other studies (28–32). Thus, in models using i.c. MCMV inoculations, it could be argued that direct damage to 
the inner ear sensory epithelium could mask important effects of  cochlear inflammation that are in addition 
to the direct cytolytic effects of  viral infection in these models. This possibility was again illustrated by results 
from a model of  HL associated with bacterial meningitis in young rats in which elevation of  ABR thresholds 
and damage to the sensory epithelium could be directly related to both the size of  the bacterial inoculum and 
intensity of  inflammatory response in the cochlea, as measured by the expression of  TNF-α (32). Although 
these data argue for a direct role of  cochlear inflammation in HL, this interpretation was also confounded by 
significant HC loss associated with higher bacterial inoculums, raising the possibility that direct effects of  the 
bacterial infection was the primary cause of  HL in these animals, and not inflammation (32). In our experi-
ments, we did not detect damage or HC loss in the sensory epithelium, but there was a significant inflamma-
tory response induced by CMV. When viewed together, these findings suggested that expression of  proinflam-
matory cytokines such as TNF-α could be an important contributor to HL, irrespective of  the preservation of  
HCs. Finally, with the exception of  damage to the sensory epithelium, there were similarities in the histologic 
findings following both routes of  infection, in that both peripheral and intracranial routes appeared to result 
in the loss of  synapses on IHCs and SGNs (32). Thus, the characteristics of  microbe-induced inflammatory 
responses in the cochlea during hearing development could define the mechanisms of  auditory dysfunction 
that develops in the absence of  loss or destruction of  the sensory epithelium.
Figure 9. Treatment of MCMV-infected mice with methylprednisolone improves auditory function. (A) Noninfected, control mice and mice infected 
with MCMV (500 PFU) as newborns were treated with vehicle (saline) alone or methylprednisolne (pred) between P3–P20, and ABR measurements were 
performed on P32 mice. For each experimental group, the number of ears was used as shown: Control+vehicle (n = 22ears), Control+pred (n = 20 ears), 
MCMV+vehicle (n = 19 ears), and MCMV+pred (n = 10 ears). Results are expressed as medians (red bar), and statistical comparisons are made by 1-way 
ANOVA with Tukey’s multiple comparisons test. (B–E) Wave I amplitudes (B and C) and latencies (D and E) from noninfected, control mice given vehicle 
(black tracing); noninfected, control mice given pred (brown tracing); MCMV-infected mice given vehicle (red tracing); and MCMV-infected mice pred (blue 
tracing) were determined. Results are expressed as means ± SD, and statistical comparisons were made by 1-way ANOVA with Tukey’s multiple compari-
sons test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
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Although we have not defined a mechanism for elevated ABR thresholds in this model of  HL following 
virus infection of  the cochlea, defective sensory cell function has been shown to result in elevated ABR and 
DPOAE thresholds in spite of  morphologically normal IHCs and OHCs. There are numerous examples of  
mouse mutants in which HC are present and appear morphologically normal by light microscopy, yet affected 
mice have elevated ABR thresholds, such as in the VGLUT3-null mouse (33). Another plausible mechanism 
that could explain the elevated ABR thresholds associated with MCMV infection is damage to the stria vas-
cularis, resulting in alterations in the endocochlear potentials. Studies have suggested that viral- or bacteri-
al-induced inflammation can disrupt vascular integrity in the stria vascularis, leading to leaky blood labyrinth 
barrier and imbalance of  the ion composition in the endolymph (34). Potentially, proinflammatory cytokines 
in the MCMV-infected cochlea could alter permeability of  the intrastrial blood labyrinth barrier (19). Thus, 
additional studies in this model could provide insight into mechanisms that contribute to inflammation-in-
duced HC dysfunction and, ultimately, elevated ABR thresholds following viral infection of  the cochlea.
Previously, we have demonstrated a significant contribution of  host innate immune responses to altered 
brain development in this model of  virus infection of  the developing CNS (20, 24). Inhibition of  host 
responses, by treatment with either pred or TNF-α neutralizing antibodies, normalized brain development 
in infected mice without significantly impacting virus replication (20, 24). A protocol similar to that used in 
these earlier studies was initially utilized to inhibit cochlear inflammation in infected mice, but results from 
several pilot experiments indicated that higher doses of  steroids were required to decrease virus-induced 
inflammation in the cochlea. This finding suggested several possibilities, including (a) the disposition of  
pred in the developing cochlea was different than in the brains of  infected mice, (b) virus-induced inflam-
mation was more robust in the cochlea than the brain, or (c) areas of  focal infection and inflammation 
in the cochlea were not readily accessible to corticosteroids delivered systemically. Consistent with these 
possibilities was the observation that, even though increased dosages of  pred decreased the inflammatory 
responses in the cochleae of  infected mice, the reduction in the expression of  IFIT1 in the cochlea was 
about 3-fold less than that achieved in the cerebella of  P8 MCMV-infected mice treated with a signifi-
cantly lower dosages of  pred (20). Nonetheless, the decrease in cochlear inflammation that followed pred 
treatment was associated with improvement, albeit very modest, in ABR thresholds when measured with 
broadband clicks, a decrease in SGN loss, and functional improvement in the growth of  the amplitude and 
latency of  wave I in ABR testing. Future modifications of  our treatment protocols will be aimed at more 
robust reductions in MCMV-induced cochlear inflammation, as we believe that HC dysfunction in this 
model system could be directly related to the level of  inflammation.
Figure 10. Treatment with methylprednisolone limits SGN loss in MCMV-infected mice. Noninfected, control or 
MCMV-infected (500 PFU) mice were treated with vehicle alone or methylprednisolne (pred) as described in Figure 9. 
Mice were harvested on P34, and the SGN density was determined. Quantification of SGN density shows the impact 
of pred treatment on preservation of SGNs in MCMV-infected mice. Medians were analyzed by 1-way ANOVA (Krus-
kal-Wallis test) with Dunn’s comparisons test. For each experimental group, the number of ears was used as shown: 
Control+vehicle (Cv; n = 6 ears), Control+pred (Cp; n = 6 ears), MCMV+vehicle (n = 10 ears), MCMV+pred (n = 6 ears). 
***P < 0.001; ****P < 0.0001.
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MCMV-infected mice with significant elevations of  ABR thresholds demonstrated poor growth in wave 
I amplitude and delays in wave I latency when compared with noninfected, control mice. It is known that 
loss of  IHC synapses can produce this effect (21, 35, 36). We have shown that the IHC synapses were fewer 
in number and had more unpaired contacts in MCMV-infected mice than in age-matched control mice. 
Furthermore, MCMV-infected cochleae revealed an overall disorganization and decreased density of  Type 
II SGN nerve fibers, and presumably Type I nerve fibers, as suggested by a decreased density at the basolat-
eral orientation of  the IHCs (Figure 5B). It is important to stress that, without the use of  antibodies against 
specific markers such as peripherin, we could not quantify the relative loss of  Type I and Type II nerve fibers 
in this study; however, we noted that, overall, there was a uniform decrease in neurites in the apex, mid, and 
base of  cochleae from infected mice as compared with controls. Overall, our findings including decreased 
wave I amplitude, reduced synapses, and damaged SGN nerve fibers suggest auditory neuropathy as a poten-
tial component of  MCMV-induced cochlear dysfunction. However, it is important to note that, in many 
model systems, SGN cell number can be significantly reduced with a notable loss of  IHC synapses, yet nor-
mal ABR thresholds are maintained (21). Thus, it is unlikely that the loss of  SGNs and IHC synapses alone 
is sufficient to explain the ABR threshold shifts that we observed in 50%–60% of  MCMV-infected mice, 
indicating that the mechanism of  ABR threshold shifts in these infected mice remain incompletely defined.
In summary, we have described cochlear histopathology that could contribute to the impaired auditory 
function in young adult mice infected with MCMV. The focal nature of  the infection, coupled with a robust 
virus-induced cochlear inflammation early in development, showed that virus-induced immunopatholo-
gy, and not direct virus cytopathic effects, was a proximal mechanism of  disease in this model of  SNHL 
associated with cCMV infection. Evidence for this mechanism of  disease in this model was obtained by 
limiting cochlear inflammation in infected mice with corticosteroids. This treatment resulted in a decrease 
in the histopathological findings in the cochlea and minimal but demonstrable improvement in auditory 
function. Thus, microbe-induced immunopathology that follows cochlear infection appears to represent a 
common thread between findings from this model of  cCMV-associated HL and those from models of  HL 
following bacterial meningitis early in auditory development (32). Importantly, deficits in ABR thresholds 
were observed in the absence of  overt loss and/or morphological damage of  HC in our study, suggesting 
that defining the nature of  inflammatory responses that lead to elevated ABR and DPOAE thresholds 
could provide critical insight into the mechanisms of  HL associated with cCMV infection and potentially 
further define mechanisms of  HL that are associated with other CNS infections.
Methods
Animals, MCMV infection, and treatment with methyl prednisolone. Pathogen-free BALB/c mice were purchased 
from Charles River Laboratories. Virus stocks were derived by reconstitution of  a molecular clone of  Smith 
MCMV (MCMV-repaired) that has been shown to be fully repaired by sequence analysis and virulence in 
vivo. Infectious virus was expanded in M2-10B4, a mouse BM stromal cell line (ATCC, CRL-1972), and 
passaged < 3 times (37, 38). Infectious virus titers of  viral stocks were determined by performing viral 
plaque assay using mouse embryonic fibroblast (MEF) and tittered in vivo to establish inoculum size for 
consistent induction of  HL in mice. Aliquoted virus stocks were stored in –80°C until used to infect ani-
mals. Newborn mouse pups, both male and female, were infected with 200 or 500 PFU of  MCMV-repaired 
virus in sterile DPBS. Virus inoculums were given by i.p. injection into newborn BALB/c mice within 12 
hours following birth, as described (39). Pregnancies were not timed but produced by cohousing of  a single 
male with 2 female mice, and pregnant mice were observed daily for delivery.
Corticosteroid treatment. In developing animals, control and MCMV-infected pups were treated on P3–P7 
by i.p. injection with pred at 18 mg/kg in saline (0.9% NaCl). Treatments were administered once per day, 
and mice were sacrificed at P8 and within 12–16 hours after the last injection. As a control, noninfected 
and MCMV-infected animals were given 50 μl of  saline once per day on P3–P7. For long-term treatments, 
pred was injected at 18 mg/kg daily on P3–P16, 9 mg/kg on P17–P18, and 4 mg/kg on P19–P20 to taper 
steroid withdrawal in treated mice.
Virus genome copy number quantitation/titer analysis and gene expression. Mice were sacrificed at various time 
points, exhaustively perfused with PBS through the left ventricle, and following perfusion, organs including 
bony labyrinth were harvested. Following isolation of  the bony labyrinth (cochlea and vestibular organ), 
any remaining bone or tissue was carefully and completely removed and DNA/RNA were isolated (n = 
8–10) using E.Z.N.A Total RNA Kit I (Omega Bio-tek) with modifications in the manufacturer’s protocol to 
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analyze viral genome copy number by quantitative PCR (qPCR). qPCR (TaqMan Gene Expression; Ther-
mo Fisher Scientific) was based on amplification of  exon 4 of  the viral immediate early-1 (IE-1) gene using 
forward primer (5′-GGC TCC ATG ATC CAC CCT GTT A-3′) and reverse primer (5′-GCC TTC ATC TGC 
TGC CAT ACT-3′), and the probe (5′-AGC CTT TCC TGG ATG CCA GGT CTC A-3′) was labeled with 
reporter dye FAM and quencher dye TAMRA. Serial dilutions of  plasmid with cloned MCMV IE-1 exon 
4 PCR product were used to generate the standard curve for quantification of  viral genome copy number. 
Samples were run in duplicate, and viral genome copy numbers are expressed as log10 genome copies per mg 
of  tissue. In preliminary studies, the viral genome copy number per mg of  tissue derived from cochlea and 
vestibular apparatus dissected from the bony labyrinth from P8-infected mice were comparable with the viral 
genome copy number per mg of  tissue when the total bony labyrinth (vestibular apparatus plus cochlea) was 
extracted. In contrast, in these same mice, the expression of  IFIT1 was approximately 2-fold higher per mg of  
tissue from the cochlea when compared with the vestibular apparatus.
For quantification of  RNA transcripts, total RNA was isolated from bony labyrinth using E.Z.N.A 
Total RNA kit (Omega Bio-tek) with modifications of  the manufacturer’s protocol. Invitrogen Super-
script III First strand synthesis (Thermo Fisher Scientific) was used to synthesize cDNA from total RNA. 
TaqMan gene expression master mix was used to detect HPRT (Mm00446968_m1), IFIT1 (Mm00515153_
m1), and TNF (Mm00443258_m1) (Invitrogen). The FAM and MGB were used as the reporter dye and the 
quencher, respectively. HPRT was used as an internal control gene, and fold change was expressed as 2–ΔΔCt. 
Values of  experimental groups were normalized to values derived from the noninfected, control group..
ABR measurements. ABRs were measured in P32–P40 noninfected and MCMV-infected mice, as well as 
in mice treated with vehicle or pred. Mice were anesthetized i.p. with ketamine (50 mg/kg) and medetomi-
dine (0.5 mg/kg). Anesthetized animals were maintained at 37°C during ABR recordings and until recovery. 
ABR equipment and software (SigGen and BioSig) from Tucker-Davis Technologies (TDT; TDT system III) 
were used to generate sound stimuli and acquire the auditory responses. ABR recordings were performed in 
a sound-proof  chamber (Industrial Acoustics Co.) using broadband click stimuli (90–20 dB in –5 dB steps) 
and tone-pips at 4, 8, 16, 32, 40, 48 kHz (90–10 dB in –10 dB steps). ABR click thresholds were divided 
into 3 categories defined as no HL (ABR threshold between 25 and 40 dB), moderate HL (ABR threshold 
between 45 and 55 dB), and severe HL (ABR threshold between 60 and 90 dB). Frequency-specific ABRs 
were obtained with 3-msec tone-pips (0.5 ms rise-fall, with a cos2 envelop, at 21/sec tone bursts) delivered to 
the ear canal. Signals were detected using 3 stainless steel needle electrodes (vertex/base of  skull, ipsilateral 
ear, low back), amplified (10,000 ×), filtered (300 Hz high-pass, 3 kHz low-pass, 60 Hz notch), and averaged 
using alternating stimulus polarity. ABR threshold was defined as the lowest intensity at which a response 
was noted. The amplitude and latency of  wave I were measured using BioSig software (TDT System III) and 
plotted against the stimulus level (dB sound pressure level [SPL]). DPOAE thresholds were measured using 
2 MF1 magnetic speakers connected to ER-10B microphone probe (Etymotic Research). The stimuli were 
applied to the ear canal in which the response was evoked using 2 primary frequencies f1 and f2 (frequency 
ratio [f1/f2] = 1.2) and recorded at 2f1-f2. DPOAE responses were measured at 8, 16, 24, and 32 kHz fre-
quencies and sound intensity from 90–20 dB at 10-dB decrements to establish threshold.
Cochlear wholemount dissection and immunofluorescence. Animals were sacrificed by CO2 overdose, perfused 
with PBS as described above, and cochleae were harvested. A small hole in the apex of the cochlea was created 
for perfusion with 4% PFA through the oval and round window. For synaptic staining, cochleae were postfixed 
in 4% PFA for 2–3 hours at 4°C rocking platform, decalcified with RDO rapid decalcifying agent (Electron 
Microscopy Science) for 4 minutes at room temperature, microdissected into 4 pieces (apex, mid-apex, mid-
base, base), and immunostained for CtBP2 and GluR2 (postsynaptic AMPA receptor subunit). Each segment 
was incubated in buffered serum (DPBS [Lonza], BSA [RPI], TritonX-100 [Thermo Fisher Scientific], and 
normal goat serum [Thermo Fisher Scientific]) for 4 hours at room temperature, followed by an overnight 
incubation in antibody dilution buffer (PBS, 0.1% TritonX-100, 5% NGS, 1% BSA) at 4°C. Additional primary 
antibodies (target, species, and source) used for immunofluorescence are listed in Supplemental Table 1. Prima-
ry antibody incubations were followed by 2-hour incubation in species/isotype-matched secondary antibodies 
conjugated with FITC, TRITC, or Alexa Fluor at room temperature and a nuclear stain, Hoechst dye (Thermo 
Fisher Scientific). After immunostaining, cochlear pieces were mounted with Vectashield (Vector Laboratories) 
onto glass slides, coverslipped, and sealed. For HC (MyosinVIIa), SC (Sox2), and nerve fibers were stained 
with an antibody reactive with NF-H stainings, cochleae were postfixed in 4% PFA overnight at 4°C on a rock-
ing platform, but all other downstream procedures were identical to the synaptic staining.
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Cochlear midmodiolar sections. To display the structures of  the SGNs and stria vascularis, cochleae 
were harvested, postfixed with 4% PFA overnight at 4°C, and decalcified. Tissues were cryoprotected in 
10% sucrose/PBS overnight, followed by 20% sucrose/PBS overnight at 4°C. Cochleae were incubated 
in 20% sucrose/OCT (1:1) solution for 2–3 hours at room temperature, embedded in OCT medium 
(Electron Microscopy Sciences), and snap frozen in 2-methylbutane/dry ice. Midmodiolar sections (10-
μm sections) of  the mouse cochleae were cut using a cryostat; sections were dried overnight at room 
temperature and stored in –80°C until ready to stain. Frozen sections were rehydrated in PBS, and 
immunostaining procedures identical to the synaptic staining were performed.
Cochlear frequency mapping. After immunostaining of  cochlear wholemounts, 10× confocal images of  
all microdissected cochlear pieces were taken in order from apex to base. Images were imported to ImageJ 
(Plugin/Tools/Measure Line, NIH), in which cochlear length was measured to subsequently map cochlear 
frequencies at 4, 5.6, 8, 11.3, 16, 22.6, 32, 45.2, and 64 kHz regions for each cochlea. The frequency map was 
used to acquire high-resolution confocal images to compare regions sensitive to the same frequency (21, 40).
Confocal imaging. For cochlear regions that correspond to 8, 16, 32, and 40 kHz frequencies, high-reso-
lution confocal z-stack images of  synapses and nerve fibers were acquired using (1.49 numerical aperture) 
100× oil-immersion total internal reflection fluorescence (TIRF) objective lens through a gallium arsenide 
phosphide (GaAsP) detector in an Olympus FV1000 confocal microscope. Additional 1.3× or 2× digital 
zoom was added to the images. The z intervals were adjusted to span the entire synaptic region of  the HCs 
in the z-dimension, with the z-step size of  1 μm/slice. Z-stack images were collapsed into a single 2-dimen-
sional image in Olympus Fluoview FV10 ASW 4.2 software capturing all synaptic puncta. Laser power and 
microscope acquisition settings were identical for all samples and regions for SGN nerve fibers, although 
minimal adjustments were made for image acquisition of  synaptic puncta or SGN density.
Cell counting. SGNs (Tuj-1), HCs/SCs (MyosinVIIa/Sox2), and synaptic puncta (CtBP2 and GluR2) in 
the cochlea were manually counted with ImageJ software (Plugins>Analyze>Cell counter, NIH). SGN soma 
within Rosenthal’s canal were counted from midmodiolar sections of  the cochlea and the total number of  
soma divided by the area of  Rosenthal’s canal to obtain density measurements (SGN cells/10,000 μm2; n = 
4 mice and n = 8 cochleae). The SGN density from each of  the 3 regions (apex, mid, and base) were aver-
aged separately using measurements obtained from individual cochlea. Additionally, 40× images of  cochlear 
wholemount were acquired, and HC and SCs were counted from cochlear segments of  apex, mid, and base 
regions, within the span of  320 μm. In addition, Type II nerve fiber innervating OHCs from the 3 regions 
were quantified within the span of  320 μm to identify the density of  nerve fibers. The number of  HC, SC, and 
nerve fibers (detected by staining for NF-H) were displayed as number of  cells or fibers per 100 μm. Lastly, the 
total number of  synaptic puncta (e.g., CtBP2 and GluR2 staining) was counted for 8 IHCs per image and was 
divided by the number of  IHCs, to gain the average number of  puncta associated with each IHC.
Statistics. For all experiments, n refers to the number of  individual mice or ears indicated in each figure 
legends. Results are expressed as mean or median ± SD. Comparison between 2 groups was performed 
using 2-tailed unpaired t test or Mann-Whitney U test, depending on normal distribution of  data. Cate-
gorical data was compared using Fisher’s exact test. All data was analyzed for normality prior to applying 
parametric or nonparametric statistical analysis. For comparing more than 2 groups, P values for all groups 
were calculated using medians by 1-way ANOVA and corrected for multiple comparisons using Krus-
kal-Wallis test for nonnormally distributed data and with Dunn’s comparisons test. For normally distribut-
ed data, P values were calculated using means by 1-way ANOVA and corrected for multiple comparisons 
using Tukey’s post hoc test. P values are indicated as *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
Study approval. All animal study procedures were approved from IACUC of  the University of  Alabama 
at Birmingham. Mice were euthanized with carbon dioxide under regulated flow. Euthanized animals were 
confirmed by cervical dislocation for adult mice and decapitation for mice younger than P12, as detailed in 
the UAB Animal Resource Program (ARP) guidelines. All animal protocols (APN9351 and APN20053) 
were approved from UAB IACUC to harvest tissues for this project.
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